Loading...
Identification of LIMK2 as a therapeutic target in castration resistant prostate cancer
This study identified LIMK2 kinase as a disease-specific target in castration resistant prostate cancer (CRPC) pathogenesis, which is upregulated in response to androgen deprivation therapy, the current standard of treatment for prostate cancer. Surgical castration increases LIMK2 expression in mous...
Na minha lista:
| Udgivet i: | Cancer Lett |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7079209/ https://ncbi.nlm.nih.gov/pubmed/30716360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2019.01.035 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|